![]() Buy Maxitrol, neomycin polymyxin BBuy Maxitrol to treat microbial infections of the anterior segment of the eye. It is an aminoglycoside antibiotic combined with a polypeptide antibiotic that is usually administered as one or two drops in the eye, four to six times daily for three or four days, reducing as the condition improves.Contraindications: You should consult a doctor before taking Maxitrol if you have glaucoma or a family history thereof, or if you are allergic to it or similar antibiotics. Athletes should be aware that taking Maxitrol may result in a false positive on a drug doping test. Maxitrol may discolor soft contact lenses, which should not be worn during application or for 15 minutes afterwards. To read more about Maxitrol side effects, Maxitrol dosage, and for more useful information about Maxitrol (neomycin polymyxin B), please click the product information link below. |
||||||||||||||
|
||||||||||||||
Other name(s): Maxitrol |
||||||||||||||
Often prescribed for bacterial infections, eye infections, conjunctivitis |
||||||||||||||
Maxitrol, neomycin polymyxin BOther names: Maxitrol
Maxitrol(Neosporin, Neomycin Polymyxin B)
The ophthalmic preparation of Maxitrol combines two antibiotics offering broad spectrum antibacterial activity with the anti-inflammatory activity of a new corticosteroid: dexamethasone, for combating certain microbial infections of the anterior segment of the eye. The suspension is formulated in an isotonic menstrum containing hydroxypropyl methylcellulose for maximum effectiveness and comfort.
Composition
Each ml: neomycin (I.N.N.) sulfate 3500 I.U., polymyxin B (I.N.N.) sulfate 6000 I.U., dexamethasone (I.N.N.) 1 mg, benzalkonium chloride (preservative) 0.04 mg., sodium chloride, polysorbate 20, hydroxypropyl methylcellulose, hydrochloric acid and / or sodium hydroxide and purified water q.s.
Indications
Maxitrol (Neosporin, Neomycin Polymyxin B) is indicated for the treatment of infectious ocular inflammations produced by organisms which are sensitive to the antibiotics Neomycin Sulphate and Polymyxin B.
Acute or chronic non-purulent conjunctivitis, blepharoconjunctivitis and keratoconjunctivitis.
Non-specific superficial keratitis, deep keratitis and acne rosacae keratitis.
Iridocyclitis.
Mild acute iritis.
Recurrent marginal ulceration.
Corneal ulcer.
Non-purulent blepharitis.
Scleritis, episcleritis and scleroconjunctivitis.
Post-operatively to aid in the prevention of ophthalmic cases of infections.
Contraindications
Maxitrol (Neosporin, Neomycin Polymyxin B) is contraindicated in persons who have shown hypersensitivity to any of its components, in tubercular, fungal and viral lesions of the eye (dendritic keratitis, herpes simplex), vaccinia, varicella, acute purulent conjunctivitis and acute purulent blepharitis. It is contraindicated in patients with a history or family history of glaucoma.
Precautions
Prolonged use of topical steroids may result in elevation of intraocular pressure (IOP) in some patients. Intraocular pressure should be routinely monitored.
In those diseases causing thinning of the cornea, perforations have been known to occur with the use of topical steroids.
Warnings
Athletes should be aware that this medication contains a component which may give a positive test result in a doping control.
Warnings about other ingredients:
This medication contains benzalkonium chloride, which may discolor soft contact lenses. If you use contact lenses, you should take them out before applying this product and they should not be worn until at least 10 to 15 minutes following the instillation of the drops.
Side Effects
Prolonged use may result in overgrowth of non-susceptible organisms, including fungi. If super infection occurs, appropriate therapy should be initiated. Some people may experience hypersensitivity to one or more components of this medication. If hypersensitivity develops with this product, discontinue use.
Incompatibilities
None reported.
Overdose
If Maxitrol (Neosporin, Neomycin Polymyxin B) is used as recommended overdose is unlikely to occur. In the case of overdose or accidental ingestion immediately consult your local poison control center and indicate the medication and the amount taken.
Dosage
One or two drops topically in the conjunctival sac four or six times daily. Dosage may be reduced after three or four days if satisfactory improvement has been obtained.
Instructions
Shake the bottle well before use.
Storage
Do not store above 25°C. Do not refrigerate. Do not allow dropper tip to touch any surface as this may contaminate the contents. This medicine must be discarded one month after first opening.
|
